Both in Pharmaceuticals
Veradermics, Incorporated vs Erasca
Over the past year MANE returned +212.1% and ERAS returned +26.4%; their daily moves had a correlation of 0.01.
MANE +212.1% ERAS +26.4%Growth of $1, one year, split-adjusted
| Metric | MANE | ERAS |
|---|---|---|
| Price | $117.82 | $14.21 |
| Market cap | $4.92B | $4.97B |
| Today | +2.45% | +0.57% |
| 1 month | +20.3% | −21.2% |
| 6 months | +93.6% | −4.9% |
| Year to date | — | +282.0% |
| 1 year | — | +583.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $819.9M | $268.7M |
| Dividend yield | — | — |
| Volatility (60d) | 66.0% | 60.0% |
| Short % of float | 17.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).